ActnerLab is a venture capital and accelerator firm based in Seoul, South Korea, established in 2012. It specializes in supporting startups in hardware, Internet of Things (IoT), and biotechnology sectors, aiding them in establishing their initial foothold and advancing their growth. The firm focuses on various markets, including bio and medical, healthcare, big data and artificial intelligence, wearable technology, human interfaces, and advanced materials. Through its investment and acceleration programs, ActnerLab aims to foster innovation and development within these dynamic industries.
Chain Lightning operates in the electric vehicle sector, focusing on providing charging station services and an app-based platform for electric vehicle users. The platform allows users to locate charging stations, schedule charging sessions, and manage their vehicle's battery health. Additionally, it offers educational content related to electric vehicles and eco-friendly living, promoting sustainable practices among its users. Through these services, Chain Lightning aims to enhance the overall experience for electric vehicle owners while contributing to the growth of eco-friendly transportation solutions.
K-Bio HealthCare
Venture Round in 2022
K-Bio HealthCare provides a personalized health record (PHR) and PHR-based digital healthcare system.
SubµLED
Venture Round in 2022
SubµLED develops and mass produces micro LED light source PKG, which is a key component of next-generation displays.
Healicure
Venture Round in 2022
Healicure is a next-generation hub platform company that connects digital healthcare services through collaboration with experts in various fields.
Dexelion
Venture Round in 2022
Dexelion specializes in software solutions for real-time depth map extraction specifically tailored for commercial CMOS Image Sensor-based cameras, including Dual- and Quad-pixel sensors. The company has developed technology that enables the generation of depth and three-dimensional object models using a single camera, eliminating the need for active light sources. This innovative approach not only reduces power consumption and physical footprint but also lowers costs, making it an attractive option for mobile and embedded systems. By providing efficient depth imaging capabilities, Dexelion addresses the growing demand for advanced visual processing in various applications.
Moth
Venture Round in 2022
Moth specializes in manufacturing advanced propellers designed to support sustainable marine industries through innovative materials and technology. Utilizing carbon composites, Moth's propellers are engineered for both marine and aerospace vehicles, enhancing propulsion efficiency. This focus on next-generation materials not only improves performance but also facilitates shorter maintenance periods for maritime and aerospace companies. By addressing the needs of these industries, Moth contributes to the advancement of more sustainable practices in marine transportation.
Four-chains
Venture Round in 2022
Four-chains is an R&D company that researches and develop cryptographic schemas, A.I. algorithms, and blockchain-based data security platforms.
AltMedical
Venture Round in 2022
AltMedical is a research institute jointly established with Dong-A University, and aims to develop a treatment for Alzheimer's disease.
Daree Technology
Venture Round in 2022
DaRee Technology is a campus startup focused on developing wearable robots that assist industrial workers, particularly those who are physically challenged or suffer from musculoskeletal disorders. The company's innovative products aim to enhance the capabilities of these workers, helping them to overcome physical limitations in their work environments. By providing support and improving mobility, DaRee Technology addresses the needs of both industrial workers and seniors, contributing to a safer and more efficient workplace.
C&SR
Venture Round in 2022
C&SR provides expertise in research and development necessary for navigating a drug candidate through humanized animal model making/testing.
Perazah
Venture Round in 2022
Perazah is engaged in the development of medical devices focused on enhancing safety and innovation in healthcare. The company operates a medical technologies development platform aimed at benefiting patients with various disorders. It specializes in creating surgical and vascular intervention robots that leverage artificial intelligence to improve the accuracy of medical procedures. By providing 2D and 3D medical imaging data and procedural guidance, Perazah's technologies help reduce radiation exposure for both patients and operators. This approach enables surgeons and medical professionals to enhance surgical procedures, chemotherapy applications, and ear, nose, and throat (ENT) treatments.
Myco-Rapha
Venture Round in 2022
Myco-Rapha is a research and development company focused on combating tuberculosis (TB) through innovative solutions. The company is developing a next-generation vaccine intended to replace the traditional BCG vaccine, addressing the urgent need for more effective TB prevention. In addition to its vaccine initiatives, Myco-Rapha is also creating a field-applied diagnostic method aimed at the early detection of TB patients. This dual approach is designed to help identify cases of tuberculosis at an earlier stage, enabling timely treatment and contributing to the eradication of the disease.
V-Memory
Seed Round in 2021
V-Memory is a technology company specializing in semiconductor manufacturing solutions. It focuses on producing thermoelectric semiconductors that enhance memory cell speed and density. The company offers solid-state cooling semiconductors that not only improve efficiency but also deliver faster memory technology. V-Memory aims to provide next-generation semiconductor memory that features a longer lifespan while addressing energy distribution imbalances. Through its innovative approach, V-Memory is positioned to advance the capabilities of semiconductor technology in various applications.
AIoT Holdings
Venture Round in 2021
AIoT Holdings is engaged in the research and development of innovative technologies that integrate artificial intelligence (AI), the Internet of Things (IoT), and blockchain. The company specializes in identity authentication solutions utilizing SecureMPC technology, which enhances security in digital transactions. Additionally, AIoT Holdings develops digital asset security products, including a digital asset vault that employs multi-party computation (MPC) to ensure the stability, security, and reliability of digital asset storage. By focusing on these advanced technologies, AIoT Holdings aims to provide users with a secure and dependable means of managing their digital assets.
Conecson
Venture Round in 2021
Conecson is focused on developing a smart portable medical device that enhances access to medical services outside traditional hospital settings. The company offers a mobile-based integrated diagnostic tool designed to assist healthcare professionals in various capacities, including telemedicine, self-examination, and volunteer medical services. Additionally, Conecson provides medical education and facilitates pre-diagnosis during long-distance travel through its telemedicine examination device and a wireless endoscope camera. These innovations enable healthcare practitioners to address spatial limitations and improve remote medical services, thereby enhancing patient care and expanding the reach of medical expertise.
PAPRICALAB
Venture Round in 2021
PAPRICALAB is a company co-founded by a radiation oncologist and a medical physicist.
Bioconnect
Venture Round in 2021
Bioconnect specializes in health management solutions by utilizing deep learning technology to collect and analyze user lifelogs. The company offers a comprehensive health management application that monitors health status and delivers services such as vision-based biometric information measurement, chronic disease management, and lab information management. By acting as a data hub that connects user-generated health data with various platforms requiring medical information, Bioconnect enables individuals and healthcare providers to maintain better oversight of health conditions and manage chronic diseases effectively.
Rapharad
Venture Round in 2021
RaphaRAD is a company focused on developing innovative radiation therapy equipment aimed at enhancing oncology treatment. Founded by a radiation oncologist and a team of five PhDs in radiotherapy, the company specializes in advanced technologies such as in-body radiation therapy and proton therapy. These technologies are designed to minimize radiation exposure to surrounding healthy tissues, allowing medical professionals to treat and potentially cure cancer while reducing the side effects associated with traditional radiation therapy.
Hexa-Check
Venture Round in 2021
Hexa-Check offers original patents for the personal 6-channel ECG.
PLANB4U
Venture Round in 2021
PLANB4U provides a total solution for one's brain that comprises the whole cycle of brain health care.
V-Memory
Seed Round in 2020
V-Memory is a technology company specializing in semiconductor manufacturing solutions. It focuses on producing thermoelectric semiconductors that enhance memory cell speed and density. The company offers solid-state cooling semiconductors that not only improve efficiency but also deliver faster memory technology. V-Memory aims to provide next-generation semiconductor memory that features a longer lifespan while addressing energy distribution imbalances. Through its innovative approach, V-Memory is positioned to advance the capabilities of semiconductor technology in various applications.
Deep Embedded Technology
Venture Round in 2020
Deep Embedded Technology researches for the meeting of deep neural network (DNN) technology of artificial intelligence and Internet of Things technology.
sesu.ai
Venture Round in 2020
Sesu.ai is a digitalization platform focused on renewable energy, specifically aimed at enhancing solar power plant monitoring. The company offers a range of services, including a virtual power plant that forecasts renewable energy usage and an IoT-based device designed to manage the production and consumption of renewable energy. Additionally, Sesu.ai provides a transaction and authentication distributed ledger, which allows businesses to generate and authenticate power statistics, record original data on power production and consumption, and deliver management data. Through these innovations, Sesu.ai supports the broader adoption of renewable energy and contributes to the development of a sustainable society.
Megnosis
Venture Round in 2020
Megnosis is a medical instrument manufacturing company focused on developing neurological devices aimed at detecting and diagnosing brain lesion diseases. The company's innovative technology incorporates transcranial current stimulation and EEG-based electroceutical systems, which stimulate brain cells and the nervous system. This approach allows healthcare professionals to treat various conditions, enhancing cognitive function and alleviating symptoms associated with ailments such as dementia and depression. Megnosis is committed to advancing medical technology and improving patient outcomes in the field of neurology.
Baikal.ai
Venture Round in 2020
Baikal.ai specializes in developing deep learning solutions aimed at early detection of cognitive impairment risks through the analysis of spontaneous speech. The company's cognitive health platform leverages natural language processing and artificial intelligence to monitor users' speech patterns, enabling the early prediction of mild cognitive impairment and its associated conditions, including Alzheimer's disease, Parkinson's disease, vascular dementia, and frontotemporal disorders. By focusing on speech analysis, Baikal.ai provides a proactive approach to cognitive health management, allowing for timely interventions and improved patient outcomes.
Molecular Bio-Technology
Venture Round in 2020
Molecular Bio-Technology improves molecular diagnostics products for Point-of-Care Testing and leads to the development of rapid and sensitive early diagnostics.
Gmeditec
Venture Round in 2020
Gmeditec is a manufacturer of medical devices focused on minimally invasive surgery. The company specializes in surgical navigation systems and balloon technology, particularly for use in endoscopic procedures. Its product offerings include advanced surgical navigation systems that integrate both electromagnetic and optical location tracking, enhancing precision during surgical interventions. By aligning clinical needs with research outcomes, Gmeditec aims to advance the development of innovative medical devices that improve patient care in the surgical field.
GhostPass
Venture Round in 2020
GhostPass is a startup that develops a biometric payment solution with A.I. and Self-Sovereign Identification technologies.
Phil Dave Music
Venture Round in 2020
Phil Dave Music started as a sheet music publishing and production company, and is currently making a leap into a Music Edu-Tech company.
DeepHelix
Venture Round in 2020
DeepHelix is an AI-based biotech company that specializes in the analysis of bio and healthcare data. It develops innovative devices designed for cancer diagnosis aimed at healthcare professionals. Utilizing advanced artificial intelligence, DeepHelix's technology is capable of analyzing medical images to assist in identifying diseases, thereby enhancing the diagnostic capabilities of doctors. This focus on AI-driven solutions positions DeepHelix at the forefront of improving healthcare outcomes through better disease recognition.
Wellcare
Venture Round in 2020
Wellcare is a digital livestock company that uses cylindrical IoT biocapsule source technology to collect and analyze the bio-data of livestock.
DC Medical
Venture Round in 2019
DC Medical Inc. is a medical device company based in Seoul, South Korea, founded in 2018. The company specializes in developing and commercializing innovative medical devices aimed at enhancing patient care and quality of life. Notable products include everybaby, a pregnancy diagnostic kit designed to help identify the risk of premature birth, and a polypropylene mesh used for treating stress urinary incontinence, pelvic organ prolapse, and hernia surgery. DC Medical stands out for implementing Korea's first NRDO (No Research Develop Only) business model in the medical device sector, focusing on providing effective solutions for pelvic organ health and related surgical needs.
Institute of Blockchain Technology and Service
Venture Round in 2019
Institute of Blockchain Technology and Service launches EOS CHROME, a public blockchain with decentralization and scalability.
OPEL Solution
Venture Round in 2019
OPEL Solution specializes in the analysis of drivers' behavior by utilizing data collected from its onboard diagnostics (OBD) dongle. This innovative device employs artificial intelligence to evaluate driving habits, identifying dangerous behaviors such as drowsy driving. By scoring these driving patterns, the OBD dongle not only alerts drivers to potential risks but also provides valuable insights to third-party applications, including insurance companies and vehicle maintenance services. The company's focus is on promoting safe and efficient driving, ultimately aiming to reduce the occurrence of traffic accidents.
Andromeda
Venture Round in 2019
Andromeda Inc. is a software development company founded in 2015 and headquartered in Tokyo, Japan, with additional offices in Seoul, South Korea, and Jakarta Selatan, Indonesia. The company specializes in creating a mobile application that enables users to connect with their school friends through features such as chat and matching. Additionally, Andromeda emphasizes the development of its own diverse cultural identity, influenced by the unique political and regional characteristics of the areas in which it operates.
Handol Biotech
Venture Round in 2019
Handol Biotech develops nano-particles including the active ingredients such as drugs inside to be targeted into the special disease.
Gosohage
Venture Round in 2019
Gosohage Inc. is a South Korean company based in Seoul that specializes in providing legal platform services through law-tech solutions. The firm focuses on leveraging technology to enhance legal processes and improve access to legal resources, making legal services more efficient and user-friendly. By integrating innovative technological approaches, Gosohage aims to transform traditional legal practices and facilitate better communication and collaboration within the legal industry.
GHbio
Venture Round in 2019
GHbio is a biotechnology company.
Mirint
Venture Round in 2019
Mirint is a company that specializes in the treatment and prevention of allergic rhinitis symptoms through the use of low-power laser therapy. It has developed a portable and lightweight laser treatment device that enhances the effectiveness of therapy with advanced laser diffusion technology. The device is designed for convenience, making it easy for users to carry and use. Additionally, it incorporates artificial intelligence to offer personalized prevention information, allowing users to connect the device to a mobile application for tracking usage. This innovative approach aims to improve the management of allergic rhinitis and enhance the overall user experience.
Procagen
Venture Round in 2019
Procagen is a genetic analysis service company based in Seongnam-si, South Korea, that specializes in predicting the risk of prostate cancer. The company employs genetic biomarkers to provide a quantitative risk score for prostate cancer, helping to identify potential patients. In addition to risk assessment, Procagen offers genetic counseling and develops personalized prevention and screening plans tailored to individual needs. The company utilizes artificial intelligence to analyze clinical, genomic, and imaging data, enhancing its ability to predict and diagnose urinary tumors and other male urinary diseases. Through its innovative approach, Procagen aims to improve early diagnosis and management of prostate cancer.
Biobankhealing
Venture Round in 2019
Biobankhealing develops innovative new drugs based on the intestinal microbial endoplasmic reticulum platform.
APEX AI
Venture Round in 2019
APEX AI focuses on risk analysis and tracking of gastric cancer using deep learning technology.
Oculight
Venture Round in 2019
Oculight is a manufacturer of medical devices focused on improving cataract surgery. The company has developed a disposable surgical instrument known as an illumination chopper, designed to enhance visibility during cataract procedures. This innovative device aims to assist medical professionals in navigating challenging surgical conditions, thereby facilitating safer and more effective surgeries. Through its specialized products, Oculight contributes to advancements in ophthalmic surgery, ultimately aiming to improve patient outcomes.
J.R. Labs
Venture Round in 2019
J.R. Labs Inc. is a biotechnology healthcare company based in Daejeon, South Korea, specializing in the production of recombinant proteins for medical applications. The company has developed advanced technology that enables the precise control of gene expression and cellular metabolism through non-coding RNA (ncRNA). J.R. Labs focuses on creating molecular therapeutics that target oncogenic ncRNAs, as well as RNA vaccines designed to combat multidrug-resistant pathogenic bacteria and cancers. Its products are available for purchase online, reflecting the company’s commitment to innovation in the biotechnology sector.
CARBOEXPERT
Venture Round in 2019
CARBOEXPERT INC. is a company based in Daejeon, South Korea, specializing in the production and supply of functional carbohydrates and standard reference materials essential for carbohydrate research. Its product range includes Maltooligosaccharide, Cyclodextrin, Glucoside, and Polysaccharides, catering to various sectors such as research, medicine, food, and cosmetics. Founded in 2015, CARBOEXPERT also offers its products through online sales, making them accessible to a broader audience in the carbohydrate research field and related industries.
Allcareable
Venture Round in 2019
Allcareable extracts essential biometric information in real-time from inpatient, clinical trial subjects, and anticancer drug users and analyzes using Deep Learning.
Peeper
Series A in 2018
Peeper is an interactive Q&A platform designed to enhance communication between fans and their favorite stars. It allows fans to submit questions to celebrities, who respond with personalized answers, often including voice messages and photos. This platform addresses the limitations of traditional social media, which primarily facilitates one-sided interactions where fans can only react to posts. By enabling fans to directly ask questions, Peeper fosters a more engaging and meaningful connection between stars and their audience. The platform not only allows for the sharing of celebrities' latest updates but also encourages community interaction among fans. Through its unique approach, Peeper transforms the fan experience, making it more interactive and personal.
V-Memory
Venture Round in 2018
V-Memory is a technology company specializing in semiconductor manufacturing solutions. It focuses on producing thermoelectric semiconductors that enhance memory cell speed and density. The company offers solid-state cooling semiconductors that not only improve efficiency but also deliver faster memory technology. V-Memory aims to provide next-generation semiconductor memory that features a longer lifespan while addressing energy distribution imbalances. Through its innovative approach, V-Memory is positioned to advance the capabilities of semiconductor technology in various applications.
Innoregen
Venture Round in 2018
Innoregen is engaged in the development and manufacture of bio-ink specifically designed for 3D bioprinting. The company produces bio-ink for both cell printing and polymer printing, which is essential for creating engineered and artificial living tissues. This bio-ink is a composite of cells, hydrogels, and polypeptides, facilitating tissue engineers in the creation of specific living tissues or organs. By providing innovative materials for 3D bioprinters, Innoregen aims to support advancements in regenerative medicine and tissue engineering, helping to replace damaged tissues and improve health outcomes.
CuroGene Life Sciences
Venture Round in 2018
CuroGene Life Sciences Co., Ltd. is a pharmaceutical company based in Cheongju, South Korea, focused on developing and commercializing AAV-based retinal gene therapeutics. The company targets the treatment of eye disorders, specifically age-related macular degeneration and diabetic retinopathy, utilizing advancements in genetic biologics to improve patient outcomes. Through its innovative approach, CuroGene Life Sciences seeks to address significant unmet medical needs in the field of ophthalmology.
Medihub
Venture Round in 2018
Medihub specializes in developing innovative medical devices, particularly an automatic injector known as "i-Ject." This device is designed to enhance the patient experience by significantly reducing injection pain while providing convenience for healthcare professionals. The automatic syringe is specifically tailored for dental local anesthesia and is applicable across various medical fields, including vaccines, urology, dermatology, and plastic surgery. Medihub's technology focuses on ensuring precise dosage and accurate drug delivery, while also enabling continuous monitoring of delivery data. By minimizing human errors associated with manual injections, Medihub aims to improve patient safety and efficiency in medical procedures.
Procuratio
Venture Round in 2018
Procuratio offers a healthcare solution focused on clinical patient monitoring and research data management. The company's platform automatically sends real-time alarms and reports to designated personnel, facilitating effective oversight in clinical settings. By integrating management features for clinical research data and addressing adverse event management, Procuratio enhances the safety and efficiency of clinical research. Additionally, the platform incorporates Internet of Things (IoT) capabilities to support the development of interconnected services essential for conducting clinical trials. This comprehensive approach enables clients to maintain smooth operations in diverse research environments.
StemOn
Venture Round in 2018
StemOn is a biotechnology company focused on developing innovative cell therapy products aimed at preventing and managing diseases. The company specializes in a digital cell therapy that leverages the characteristics of secreted hair cells. Utilizing automated equipment known as UltraRepro, StemOn's technology facilitates the secretion of exosomes, which are essential for cellular communication. This process involves the fusion of multivesicular bodies with the cell membrane, allowing the delivery of growth factors and various proteins, including cytokines, nucleic acids, and lipids, to recipient cells. By streamlining the production of these exosomes, StemOn aims to reduce the time and cost involved in research and therapeutic applications.
MK Meditech
Venture Round in 2018
MK Meditech provides clinical solutions in Orthodontics and OSAS treatment with a state-of-art palatal expansion appliance.
CdmoGen
Venture Round in 2018
CdmoGen specializes in the manufacturing and testing of biopharmaceuticals and gene therapeutic products. The company offers both GMP and non-GMP manufacturing services, as well as GMP and GLP testing, focusing on the development of virus-based advanced biopharmaceuticals. CdmoGen aims to enhance gene and cell therapy by providing quality evaluation and analysis of vaccine and viral biopharmaceuticals, ultimately supporting the development of improved virus-based gene therapies and drugs for patients.
IMPACT KOREA
Venture Round in 2018
IMPACT KOREA provides medical pumps that can be applied to surgery, procedures, emergency patients, and intensive care units.
Genoheal
Venture Round in 2018
Genoheal collaborates R&D and research partnerships with clinical trial labs and pharmaceutical manufacturing and sales companies. The company focuses on new drug discovery based on technological excellence, the development of functional ingredients, and continuous research and development.
Cella Biotech
Venture Round in 2018
CELLA Biotech focuses on the development and manufacturing of medical devices and laboratory equipment aimed at the life sciences sector. The company offers a range of products and services that encompass the entire industry, including three-dimensional design, circuit design, software and firmware development, and prototype production. Additionally, CELLA Biotech provides advanced automation equipment and testing analysis tools, supporting users in obtaining cutting-edge technological solutions within the biotechnology field.
Wave-I
Venture Round in 2018
Wave-I is an independent entity that curates and produces art exhibitions that introduces the works of established and emerging artists.
Hessed Edu
Venture Round in 2018
Hessed Edu is an educational content provider that specializes in STEAM (Science, Technology, Engineering, Arts, and Mathematics) materials for students aged 3 to 10 years. The company has developed over 500 unique educational resources that are utilized by approximately 500 educational institutions. Hessed Edu's platform focuses on creating textbooks and content that facilitate step-by-step learning across a variety of subjects, aiming to nurture both scientific creativity and humanistic imagination in students. By prioritizing character development alongside academic knowledge, Hessed Edu seeks to enhance the educational experience for young learners.
V-Nature
Venture Round in 2018
V-Nature is a Greenbiology startup that manufactures ionized Vanadium, an anti-diabetic medical material with Insulin-mimic function.
Morethings
Venture Round in 2018
Morethings is a provider of innovative smart healthcare products designed to enhance quality of life. The company specializes in IoT-based posture correction yoga mats that monitor body practices, contributing to improved physical well-being. These intelligent mats not only support yoga and posture correction but also track sleep quality, providing alerts in case of emergencies during sleep. Morethings focuses on delivering real-time data transmission and interactive educational features, empowering customers to take charge of their health and learn new skills. Through its products, Morethings aims to foster a holistic approach to personal wellness.
FEROKA
Venture Round in 2018
Feroka is a biotechnology company focused on advancing drug delivery technologies through its innovative multi-layer microneedle patch platform. This system allows for precise delivery of medications in specific volumes by utilizing micrometer-sized needles that effectively penetrate the skin. The unique design features a rapidly melting shaft that facilitates easy removal of the patch while ensuring that the drug-containing needle layer can deliver active ingredients to various skin layers, including the epidermis and dermis. Feroka aims to commercialize its microneedle technology for applications in vaccines and gene therapy, with a particular emphasis on treating rare diseases such as epidermolysis bullosa.
Y-IN
Venture Round in 2018
Y-IN Inc. is a South Korean company specializing in biocompatible and ultra-thin polymer coating services tailored for the medical industry. It focuses on developing advanced polymer materials and employs chemical vapor deposition (CVD) technology to enhance the functionality of various medical devices, including surgical instruments, probes, and ultrasound equipment. Additionally, Y-IN manufactures perylene vapor equipment that serves multiple sectors, such as electronics, automotive, aerospace, and military applications. This technology addresses challenges related to adhesion between perylene coatings and product interfaces, thereby providing effective solutions for clients across diverse industries.
TRICUBICS
Angel Round in 2017
Tricubics offers 3D modeling service.
D EMPTYSPACE
Seed Round in 2017
D Emptyspace is a mobile application developed by DIFT Corp., which was founded in 2015 and is based in Seoul, South Korea. The application allows users to create immersive virtual galleries where they can customize their exhibition spaces using various templates. Users have the ability to invite friends and connect with other creators, fostering relationships among artists, critics, and collectors. D Emptyspace provides a platform for artists to curate their own spaces, share their stories, and present their work in a personalized manner. Additionally, the app facilitates the discovery of new and emerging artists, enhancing the overall experience of exploring and appreciating art in a virtual environment.
ARTIFEX
Venture Round in 2017
ARTIFEX is a production specialty company for the walking frame that helps elderly people who have difficulty moving around.
Shema
Venture Round in 2017
Shema develops and distributes smart masks for public health in a serious situations like air pollution.
KBioLab
Venture Round in 2017
KBioLab is a biotechnology company that helps build healthy lives through microorganisms.
Smart Checking Fixture
Venture Round in 2017
Smart Checking Fixture provides a 3D digital solution that enables the comparison of CAD data with the scan data of car parts.
Retrofit Korea
Venture Round in 2017
Retrofit Korea Co., Ltd., founded in 2015 and based in Ulsan, South Korea, specializes in engineering services for power plants, shipbuilding, and marine sectors. The company offers a range of solutions including Ballast Water Treatment Systems (BWTS), offshore reverse engineering, and consulting services. Additionally, Retrofit Korea utilizes advanced technology such as the BLK360 image scanner to provide 3D spatial data essential for remodeling and repair projects. Currently, the company operates in stealth mode, focusing on innovative approaches in its field.
Toysvill
Venture Round in 2017
Toysvill is an art community, a virtual and real space for creating personal artwork by coloring and crafting the platform toys.
Benedea
Venture Round in 2017
Benedea Inc. is a software company based in Seoul, South Korea, incorporated in 2014. The company specializes in developing Han, a mobile input software that allows users to type simplified Chinese characters directly, eliminating the need to convert from Roman alphabet pronunciations. Additionally, Benedea's software supports typing Japanese kanji, enhancing its utility for users of both languages.
Tecozyme
Venture Round in 2017
Tecozyme Inc is a company based in Seoul, South Korea, that specializes in developing dental products aimed at maintaining a healthy oral ecosystem. Its product offerings include self-cleaning dental implants, a photodynamic healing abutment designed for dental plaque removal, zinc vita 21, and a patch for bad breath removal. Tecozyme focuses on innovative solutions that promote dental health and hygiene.
LARTBIO
Venture Round in 2017
LARTBIO is a transgenic animal development company focused on creating transgenic embryos from somatic cells. The company specializes in advanced genetic technologies, including genetic scissors, which have applications in various fields. These applications include bovine fertilized egg transplantation, the development of non-viral cell lines, and the production of genetically modified animals, such as rats. LARTBIO also works on producing functional milk and albumin through genetically modified cows, as well as developing animal pharmaceuticals and cosmetic materials. Through these innovations, LARTBIO aims to support commercialization efforts in functional milk, animal products, and human health markets.
kozaza.com
Venture Round in 2017
Kozaza Inc. is a home sharing platform based in Seoul, South Korea, specializing in a variety of unique and affordable accommodations, including homestays, apartments, guesthouses, and traditional Korean houses known as Hanoks. The name "Kozaza" reflects its mission to provide a restful experience, translating to "sleep well as baby" in Korean. Since its designation as a sharing company by the Seoul Metropolitan Government in 2013, Kozaza has partnered with local governments to promote a new culture of accommodation for foreign visitors. The platform emphasizes local service and cost-effectiveness, offering lower service fees and special promotions with local hosts. Kozaza aims to enhance the travel experience in Korea by providing diverse lodging options tailored to various preferences.
GaGyo Tech
Venture Round in 2017
GaGyo Tech develops a prototype of a non-Virus DBD plasma air purifier for vehicles. The company's patented technology generates a magnetic field by adding variable current to plasma and removing harmful substances.
SENSORTOPIA
Venture Round in 2017
SENSORTOPIA develops rain sensors that check the raindrop status and activate the automatic wiper system without any attention from the driver.
Ballop
Venture Round in 2017
Ballop is a local brand specializing in a diverse range of sports shoes and clothing, including aqua shoes designed for the Korean market. The company provides various apparel and accessories tailored for water sports and other athletic activities, ensuring that customers have access to suitable sports clothing for all four seasons. By focusing on quality and functionality, Ballop aims to meet the needs of active individuals while promoting a lifestyle centered around sports and outdoor activities.
D&J Humancare helps people who are poor at managing their health to improve their health care.
Vovi C&E
Venture Round in 2017
VOVI C&E Co., Ltd., established in 2013 and based in Seoul, South Korea, specializes in the research and development of bio raw materials with antioxidant and anti-bacterial properties. The company manufactures products such as Suda Calxy, a health functional food that utilizes ingredients designed to enhance human health. VOVI C&E focuses on producing hydrogen-storing antioxidant materials through environmentally friendly methods, aiming to innovate in the hydrogen sector. Its offerings are geared towards enhancing cell energy generation and providing robust antioxidant capabilities, catering to clients seeking advancements in health and technology.
InniTech
Venture Round in 2017
InniTech develops a golf distance measuring system for professional and amateur players.
Spryfit
Venture Round in 2016
Spryfit, Inc. is a fitness technology company that offers a reward-based gaming platform designed to motivate users in achieving their health and fitness goals. Established in 2016 and based in Wilmington, Delaware, Spryfit enables participants to engage in fitness challenges using wearable devices and fitness apps. The platform leverages health data from these devices to create virtual communities that foster collaboration and competition among users. By incorporating cash prizes into its challenges, Spryfit aims to enhance motivation and encourage individuals to adopt healthier lifestyles. The application tracks various fitness metrics, such as step count, distance, and duration, and automatically adjusts to local time zones, making it accessible and user-friendly for participants.
Infit & Company
Seed Round in 2016
Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.
L-base
Venture Round in 2016
L-Base focuses on the development of innovative anti-cancer drugs and autophagy inhibitors aimed at improving treatment outcomes for patients. The company is dedicated to creating therapeutic agents that specifically target autophagy, a cellular process that can contribute to drug resistance in cancer therapies. By utilizing CAGE-derived peptides, L-Base seeks to enhance the effectiveness of existing anticancer treatments while minimizing potential side effects associated with traditional chemotherapy. This approach aims to provide patients with more effective and safer options in their fight against cancer.
Feagle
Venture Round in 2016
Feagle uses revolutionary transdermal drug delivery to enhance epidermal growth factors for treating skin problems.
ChemE
Venture Round in 2016
ChemE is a manufacturer of LCD, OLED, micro-LED, and electronic materials.
Olive Healthcare is a digital healthcare company specializing in medical diagnostic devices with a focus on abdominal fat scanning and breast cancer diagnosis. Utilizing non-radiative and non-invasive near infrared (NIR) technology, along with artificial intelligence algorithms and big data processing, Olive Healthcare offers customized medical services. Their devices are designed to measure abdominal fat status and provide tailored exercise and diet guidance, helping users to reduce belly fat and mitigate the risk of metabolic diseases. Through these innovative approaches, Olive Healthcare aims to enhance patient care and improve health outcomes.
Alpha Clo
Venture Round in 2016
Alpha Clo develops and sells two types of (B2B, B2C) products in order to differentiate from existing smart clothing products.
39 degrees C
Venture Round in 2016
39 degrees C is a media application development company that specializes in innovative video streaming solutions. The company has developed two key applications: LILAY and feedeo. LILAY stands out as a multi-camera live streaming app that enables users to share camera screens between smartphones, facilitating real-time video shooting and transmission without the need for additional equipment. This is achieved through a unique technology called WiFi-Direct, which is patented both domestically and internationally. Feedeo complements this offering by providing users with a video-making platform featuring various stylish templates, allowing for the creation of engaging online stories and social media content. Together, these applications enable users to conduct live streams and broadcast their content to a wide audience, making video production accessible and efficient.
Landymoss
Venture Round in 2016
Landymoss allows travelers to compare and choose hotels on their destinations.
Virocure
Venture Round in 2016
ViroCure, Inc. is a biotechnology company based in Seoul, South Korea, focused on the development of oncolytic viruses for cancer treatment and vaccine development. The company specializes in creating viruses that selectively infect and destroy cancer cells while stimulating anti-cancer immune responses, aiming to minimize side effects on normal cells. ViroCure's product lineup includes RC402, which targets metastatic gastric and lung cancers; RP116, effective against oral cancers, salivary gland cancer, soft tissue sarcoma, and melanoma; MC509, a rabbit-specific poxvirus; and SC717, designed to combat tumors in animal models. Through its innovative virus discovery platform, ViroCure seeks to enhance treatment options for cancer patients.
Genesystem
Venture Round in 2016
Genesystem is a biotech engineering company focused on molecular diagnostics and testing solutions. It develops and markets advanced PCR instruments, along with related reagents and microfluidic devices, aimed at improving health outcomes and enhancing the quality of life. The company also offers customized engineering services tailored to the needs of clients in the biotechnology sector, leveraging its expertise to add value to various applications in the field.
Roborus
Venture Round in 2016
Roborus, founded in 2016 in Seoul, South Korea, specializes in smart ordering SaaS solutions that leverage facial recognition and advanced AI technology to enhance customer experiences in the restaurant industry. The company’s system automates customer identification and utilizes machine learning to analyze data such as visit frequency, consumption patterns, and average spending. This allows businesses to offer personalized services by recommending menu items tailored to individual customer profiles. With a team boasting over 50 years of experience in AI, robotics, and international business, Roborus aims to help restaurants save time, increase profits, and gain deeper insights into their customer base. The company is recognized as a graduate of the METRO Accelerator Powered by Techstars.
G+FLAS Life Sciences
Seed Round in 2016
G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.
MEDITULIP
Venture Round in 2015
MEDITULIP is a manufacturer of medical devices focused on advancing surgical practices and cancer treatment. The company specializes in creating innovative tools for minimally invasive surgeries, including a unique asymmetrical linear stapler designed to facilitate tissue sampling for frozen section biopsies. This device aids surgeons in confirming the effectiveness of cancer surgeries during the operation, thereby enhancing surgical efficiency and patient outcomes. MEDITULIP's commitment to developing advanced medical technology positions it as a key player in the field of surgical innovation.
WizMeta
Venture Round in 2015
WizMeta is developing a meta-video mash-up solution and plans to provide a global platform service based on the solution. The solution will help on-the-top (OTT) service providers to increase their revenue. By doing this, WizMeta aims to contribute to, and ultimately progress, the video industry and its respective market in a way that will enhance and improve the possibilities in which users interact with the video medium—a growth that will reinvent and revolutionize the way that we enjoy videos. Its defining technology is a patent that offers a new way of clipping and reviewing movies and videos. It is on how services can be offered so that users enjoy movies and videos by virtual clipping and review fast and seamlessly. We call such virtual clips, MetaVideos™. The company is building its accompanying tool, “MetaVideo™ Player†(MVP). MVP will serve as the fundamental platform for the services rendered by the patented technology. MVP will allow users to clip, mash up, and regenerate (i.e. define) content according to their particular interests and purposes. With the MVP, users will begin to clip, mash up and define movies and videos that may be available on YouTube, Vimeo, Hulu, Netflix, TED, Viki, MLB, ESPN, CNN, NBC, FOX, and so on, according to their respective interests and purposes. Subsequently, the users will share their defined clips, with friends and associates over social media.
IMGT
Venture Round in 2015
IMGT is a South Korean company based in Seongnam-si, established in 2010, that specializes in the development of drugs and therapeutic technologies utilizing nanotechnology for image-guided therapy. The company focuses on creating innovative biomedical solutions aimed at enhancing the precision and effectiveness of medical treatments through advanced imaging techniques.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.